Drugs with Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS
✉ Email this page to a colleague
Drugs with Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | Dosage |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | REVEX | nalmefene hydrochloride | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 020459-001 | Apr 17, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | ||||
Hikma | REVEX | nalmefene hydrochloride | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 020459-002 | Apr 17, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | ||||
Fresenius Kabi Usa | GLYCOPYRROLATE | glycopyrrolate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 214919-001 | Apr 21, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | ||||
Intl Medication Sys | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 211880-001 | Apr 24, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | |||
Hospira | MAGNESIUM SULFATE | magnesium sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 075151-001 | Apr 25, 2000 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | |||
Exela Pharma | GLYRX-PF | glycopyrrolate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 210997-003 | Apr 9, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration | >Dosage |